Synthes gets US nod for thoracic disorder implant
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale an implantable device for treating children with thoracic insufficiency syndrome (TIS)- severe deformities of the chest, spine, and ribs that prevent normal breathing and lung development.